Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.53M Sell
32,949
-4,988
-13% -$549K 1.07% 46
2026
Q1
$3.99M Buy
37,937
+117
+0.3% +$13.7K 1.29% 38
2025
Q4
$4.72M Buy
37,820
+172
+0.5% +$20.5K 1.46% 33
2025
Q3
$4.51M Sell
37,648
-8,178
-18% -$864K 1.41% 28
2025
Q2
$4.21M Buy
45,826
+2,200
+5% +$201K 1.25% 33
2025
Q1
$3.84M Buy
43,626
+12,975
+42% +$1.28M 1.27% 35
2024
Q4
$2.84M Buy
30,651
+37
+0.1% +$3.56K 0.91% 44
2024
Q3
$2.84M Buy
30,614
+1,826
+6% +$153K 0.92% 42
2024
Q2
$2.16M Buy
28,788
+7,919
+38% +$632K 0.73% 54
2024
Q1
$1.8M Buy
+20,869
New +$1.6M 0.61% 61

Other funds holding CRH

Cloverfields Capital Group's CRH Position: Q2 2026 in Review

Cloverfields Capital Group reduced its CRH (CRH) stake by 13% in Q2 2026, selling an estimated $549K and leaving 32,949 shares worth $3.53M. The position accounts for 1.07% of the portfolio, ranked #46.

Cloverfields Capital Group first reported a position in CRH in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.72M in Q4 2025. 1,031 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Cloverfields Capital Group held 32,949 shares of CRH worth $3.53M as of Q2 2026.
  • Cloverfields Capital Group sold 4,988 CRH shares in Q2 2026, an estimated $549K.
  • CRH made up 1.07% of Cloverfields Capital Group's portfolio in Q2 2026, its #46 holding.
  • Cloverfields Capital Group first reported a position in CRH in Q1 2024 and has held it in 10 quarters since.
  • Cloverfields Capital Group's CRH position peaked at $4.72M in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Cloverfields Capital Group's 13F filing for Q2 2026, filed 13 Aug 2026.